Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""covid-19"" wg kryterium: Temat


Tytuł:
What is the true place of the SARS-CoV-2 rapid point-of-care antigen test in the hospital setting? Lessons learned from real life.
Autorzy:
Roger S; Département de Biologie des Agents Infectieux, Laboratoire de Virologie, CHU Angers, Angers, France.
Lefeuvre C; Département de Biologie des Agents Infectieux, Laboratoire de Virologie, CHU Angers, Angers, France.; Department of Virology, HIFIH, SFR ICAT, University of Angers, Angers, France.
Pivert A; Département de Biologie des Agents Infectieux, Laboratoire de Virologie, CHU Angers, Angers, France.; Department of Virology, HIFIH, SFR ICAT, University of Angers, Angers, France.
Ducancelle A; Département de Biologie des Agents Infectieux, Laboratoire de Virologie, CHU Angers, Angers, France.; Department of Virology, HIFIH, SFR ICAT, University of Angers, Angers, France.
Savary D; Département de Médecine des Urgences, CHU Angers, Angers, France.
Bouthry É; Département de Biologie des Agents Infectieux, Laboratoire de Virologie, CHU Angers, Angers, France.; Department of Virology, HIFIH, SFR ICAT, University of Angers, Angers, France.
Le Guillou-Guillemette H; Département de Biologie des Agents Infectieux, Laboratoire de Virologie, CHU Angers, Angers, France.; Department of Virology, HIFIH, SFR ICAT, University of Angers, Angers, France.
Pokaż więcej
Źródło:
Journal of medical virology [J Med Virol] 2022 Apr; Vol. 94 (4), pp. 1723-1727. Date of Electronic Publication: 2021 Dec 13.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19 Serological Testing*
Hospitals*
Point-of-Care Testing*
COVID-19/*diagnosis
SARS-CoV-2/*isolation & purification
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antigens, Viral/blood ; COVID-19/prevention & control ; COVID-19 Nucleic Acid Testing ; Female ; Humans ; Male ; Middle Aged ; SARS-CoV-2/genetics ; SARS-CoV-2/immunology ; Sensitivity and Specificity ; Time Factors ; Young Adult
Czasopismo naukowe
Tytuł:
Evaluation of the diagnostic features and clinical course of COVID-19 vaccine-associated subacute thyroiditis.
Autorzy:
Bostan H; Department of Endocrinology and Metabolism, University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital, Ziraat Mahallesi, Şht. Ömer Halisdemir Blv No. 1, 06110, AltindagAnkara, Turkey. .
Kayihan S; Department of Endocrinology and Metabolism, University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital, Ziraat Mahallesi, Şht. Ömer Halisdemir Blv No. 1, 06110, AltindagAnkara, Turkey.
Calapkulu M; Department of Endocrinology and Metabolism, University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital, Ziraat Mahallesi, Şht. Ömer Halisdemir Blv No. 1, 06110, AltindagAnkara, Turkey.
Hepsen S; Department of Endocrinology and Metabolism, University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital, Ziraat Mahallesi, Şht. Ömer Halisdemir Blv No. 1, 06110, AltindagAnkara, Turkey.
Gul U; Department of Endocrinology and Metabolism, University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital, Ziraat Mahallesi, Şht. Ömer Halisdemir Blv No. 1, 06110, AltindagAnkara, Turkey.
Ozturk Unsal I; Department of Endocrinology and Metabolism, University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital, Ziraat Mahallesi, Şht. Ömer Halisdemir Blv No. 1, 06110, AltindagAnkara, Turkey.
Kizilgul M; Department of Endocrinology and Metabolism, University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital, Ziraat Mahallesi, Şht. Ömer Halisdemir Blv No. 1, 06110, AltindagAnkara, Turkey.
Sencar ME; Department of Endocrinology and Metabolism, University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital, Ziraat Mahallesi, Şht. Ömer Halisdemir Blv No. 1, 06110, AltindagAnkara, Turkey.
Cakal E; Department of Endocrinology and Metabolism, University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital, Ziraat Mahallesi, Şht. Ömer Halisdemir Blv No. 1, 06110, AltindagAnkara, Turkey.
Ucan B; Department of Endocrinology and Metabolism, University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital, Ziraat Mahallesi, Şht. Ömer Halisdemir Blv No. 1, 06110, AltindagAnkara, Turkey.
Pokaż więcej
Źródło:
Hormones (Athens, Greece) [Hormones (Athens)] 2022 Sep; Vol. 21 (3), pp. 447-455. Date of Electronic Publication: 2022 Jun 16.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/diagnosis
COVID-19*/epidemiology
COVID-19*/prevention & control
COVID-19 Vaccines*/adverse effects
Thyroiditis, Subacute*/diagnosis
Thyroiditis, Subacute*/epidemiology
Thyroiditis, Subacute*/etiology
COVID-19 Testing ; Humans ; Retrospective Studies
Czasopismo naukowe
Tytuł:
COVID-19 vaccine effectiveness among people living with and without HIV in South Carolina, USA: protocol of a population-based cohort study.
Autorzy:
Xueying Y; Health Promotion, Education and Behavior, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, USA .; South Carolina SmartState Center for Healthcare Quality, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, USA.
Zhang J; South Carolina SmartState Center for Healthcare Quality, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, USA.; Epidemiology and Biostatistics, University of South Carolina Arnold School of Public Health, Columbia, South Carolina, USA.
Olatosi B; South Carolina SmartState Center for Healthcare Quality, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, USA.; Health Services, Policy and Management, University of South Carolina Arnold School of Public Health, Columbia, South Carolina, USA.
Weissman S; South Carolina SmartState Center for Healthcare Quality, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, USA.; Internal Medicine, University of South Carolina School of Medicine, Columbia, South Carolina, USA.
Li X; Health Promotion, Education and Behavior, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, USA.; South Carolina SmartState Center for Healthcare Quality, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, USA.
Pokaż więcej
Źródło:
BMJ open [BMJ Open] 2022 Aug 23; Vol. 12 (8), pp. e067095. Date of Electronic Publication: 2022 Aug 23.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
HIV Infections*/complications
HIV Infections*/epidemiology
COVID-19 Testing ; COVID-19 Vaccines/therapeutic use ; Cohort Studies ; Humans ; SARS-CoV-2 ; South Carolina/epidemiology ; Vaccine Efficacy
Czasopismo naukowe
Tytuł:
Real-world effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection among adolescents (12 to 17-year-olds) in Malaysia.
Autorzy:
Husin M; Institute for Clinical Research, National Institutes of Health, Ministry of Health Malaysia, Setia Alam, 40170, Malaysia. Electronic address: .
Tok PSK; Institute for Clinical Research, National Institutes of Health, Ministry of Health Malaysia, Setia Alam, 40170, Malaysia. Electronic address: .
Suah JL; Institute for Clinical Research, National Institutes of Health, Ministry of Health Malaysia, Setia Alam, 40170, Malaysia.
Thevananthan T; Disease Control Division, Ministry of Health Malaysia, Putrajaya, 62590, Malaysia.
Tng BH; Institute for Clinical Research, National Institutes of Health, Ministry of Health Malaysia, Setia Alam, 40170, Malaysia.
Peariasamy KM; Institute for Clinical Research, National Institutes of Health, Ministry of Health Malaysia, Setia Alam, 40170, Malaysia.
Sivasampu S; Institute for Clinical Research, National Institutes of Health, Ministry of Health Malaysia, Setia Alam, 40170, Malaysia.
Pokaż więcej
Źródło:
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2022 Aug; Vol. 121, pp. 55-57. Date of Electronic Publication: 2022 Apr 30.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
Vaccines*
Adolescent ; BNT162 Vaccine ; COVID-19 Testing ; COVID-19 Vaccines ; Humans ; Malaysia/epidemiology ; SARS-CoV-2
Czasopismo naukowe
Tytuł:
Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer.
Autorzy:
Pinato DJ; Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, London, UK; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
Ferrante D; Department of Translational Medicine, Unit of Medical Statistics, University of Piemonte Orientale, Novara, Italy.
Aguilar-Company J; Medical Oncology, Vall D'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain; Infectious Diseases, Vall D'Hebron University Hospital, Barcelona, Spain.
Bower M; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK.
Salazar R; Department of Medical Oncology, ICO L'Hospitalet, Oncobell Program (IDIBELL), CIBERONC, Hospitalet de Llobregat, Spain.
Mirallas O; Medical Oncology, Vall D'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain.
Sureda A; Haematology Department, ICO Hospitalet, Hospitalet de Llobregat, IDIBELL, Universitat de Barcelona, Barcelona, Spain.
Bertuzzi A; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
Brunet J; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain.
Lambertini M; Medical Oncology Department, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy.
Maluquer C; Haematology Department, ICO Hospitalet, Hospitalet de Llobregat, IDIBELL, Universitat de Barcelona, Barcelona, Spain.
Pedrazzoli P; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; Department of Internal Medicine and Medical Therapy, University of Pavia, Pavia Italy.
Biello F; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
Lee AJX; Cancer Division, University College London Hospitals, London, UK.
Sng CCT; Cancer Division, University College London Hospitals, London, UK.
Liñan R; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain.
Rossi S; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
Carmona-García MC; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain.
Sharkey R; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK.
Eremiev S; Medical Oncology, Vall D'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain.
Rizzo G; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Bain HD; Cancer Division, University College London Hospitals, London, UK.
Yu T; Cancer Division, University College London Hospitals, London, UK.
Cruz CA; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain.
Perachino M; Medical Oncology Department, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy.
Saoudi-Gonzalez N; Medical Oncology, Vall D'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain.
Fort-Culillas R; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain.
Doonga K; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK.
Fox L; Department of Hematology, Vall D'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain.
Roldán E; Medical Oncology, Vall D'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain.
Zoratto F; Medical Oncology, St Maria Goretti Hospital, Latina, Italy.
Gaidano G; Division of Haematology, Department of Translational Medicine, University of Piemonte Orientale and Maggiore Della Carità Hospital, Novara, Italy.
Ruiz-Camps I; Infectious Diseases, Vall D'Hebron University Hospital, Barcelona, Spain.
Bruna R; Division of Haematology, Department of Translational Medicine, University of Piemonte Orientale and Maggiore Della Carità Hospital, Novara, Italy.
Patriarca A; Division of Haematology, Department of Translational Medicine, University of Piemonte Orientale and Maggiore Della Carità Hospital, Novara, Italy.
Shawe-Taylor M; Cancer Division, University College London Hospitals, London, UK.
Fusco V; Oncology Unit and Centro Documentazione Osteonecrosi, Azienda Ospedaliera 'SS Antonio e Biagio e Cesare Arrigo', Alessandria, Italy.
Martinez-Vila C; Fundació Althaia Manresa, Manresa, Spain.
Berardi R; Medical Oncology, AOU Ospedali Riuniti, Polytechnic University of the Marche Region, Ancona, Italy.
Filetti M; Medical Oncology, St. Andrea Hospital, Rome, Italy.
Mazzoni F; Medical Oncology, Careggi University Hospital, Florence, Italy.
Santoro A; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini, 20090 Pieve Emanuele, Milan, Italy.
Delfanti S; Mesothelioma Unit, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.
Parisi A; Department of Life, Health & Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
Queirolo P; Melanoma and Sarcoma Medical Treatment Unit, IEO - Istituto Europeo di Oncologia, Milan, Italy.
Aujayeb A; Respiratory Department, Northumbria Healthcare NHS Foundation Trust, North Shields, UK.
Rimassa L; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini, 20090 Pieve Emanuele, Milan, Italy.
Prat A; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain.
Tabernero J; Medical Oncology, Vall D'Hebron University Hospital and Institute of Oncology (VHIO), IOB-Quiron, UVic-UCC, Barcelona, Spain.
Gennari A; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
Cortellini A; Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, London, UK. Electronic address: .
Pokaż więcej
Corporate Authors:
OnCovid study group
Źródło:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Aug; Vol. 171, pp. 64-74. Date of Electronic Publication: 2022 May 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
Neoplasms*/complications
Neoplasms*/therapy
COVID-19 Testing ; COVID-19 Vaccines ; Humans ; Morbidity ; SARS-CoV-2 ; Vaccination
Czasopismo naukowe
Tytuł:
COVID-19 Vaccination and Remdesivir are Associated With Protection From New or Increased Levels of Donor-Specific Antibodies Among Kidney Transplant Recipients Hospitalized With COVID-19.
Autorzy:
Killian JT Jr; Department of Surgery, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Houp JA; Department of Surgery, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Burkholder GA; Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Roman Soto SA; Department of Surgery, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Killian AC; Department of Surgery, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Ong SC; Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Erdmann NB; Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Goepfert PA; Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Hauptfeld-Dolejsek V; Department of Surgery, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Leal SM Jr; Department of Pathology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Zumaquero E; Department of Microbiology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Nellore A; Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Agarwal G; Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Kew CE; Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Orandi BJ; Department of Surgery, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Locke JE; Department of Surgery, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Porrett PM; Department of Surgery, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Levitan EB; School of Public Health, University of Alabama at Birmingham, Birmingham, AL, United States.
Kumar V; Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Lund FE; Department of Microbiology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Pokaż więcej
Źródło:
Transplant international : official journal of the European Society for Organ Transplantation [Transpl Int] 2022 Jul 19; Vol. 35, pp. 10626. Date of Electronic Publication: 2022 Jul 19 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/drug therapy
COVID-19*/prevention & control
Kidney Transplantation*
Adenosine Monophosphate/analogs & derivatives ; Alanine/analogs & derivatives ; Antibodies ; COVID-19 Testing ; COVID-19 Vaccines/therapeutic use ; Graft Rejection ; HLA Antigens ; Humans ; Pandemics ; SARS-CoV-2 ; Transplant Recipients ; Vaccination
SCR Protocol:
COVID-19 drug treatment
Czasopismo naukowe
Tytuł:
COVID-19 Testing: A Qualitative Study Exploring Enablers and Barriers in the Greater Accra Region, Ghana.
Autorzy:
Ha S; Seoul National University Graduate School of Public Health, Seoul, South Korea.
Yangchen S; Institute of Health Partners, Thimphu, Bhutan.
Assan A; Global Policy and Advocacy Network (GLOOPLAN), Accra, Ghana.
Pokaż więcej
Źródło:
Frontiers in public health [Front Public Health] 2022 Jul 12; Vol. 10, pp. 908410. Date of Electronic Publication: 2022 Jul 12 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/diagnosis
COVID-19*/epidemiology
COVID-19 Testing ; COVID-19 Vaccines ; Ghana/epidemiology ; Humans ; Pandemics
Czasopismo naukowe
Tytuł:
SARS-CoV-2 infection, vaccination, and antibody response trajectories in adults: a cohort study in Catalonia.
Autorzy:
Karachaliou M; Barcelona Institute for Global Health (ISGlobal), Doctor Aiguader, 88, 08003, Barcelona, Spain. .
Moncunill G; Barcelona Institute for Global Health (ISGlobal), Doctor Aiguader, 88, 08003, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Barcelona, Spain.
Espinosa A; Barcelona Institute for Global Health (ISGlobal), Doctor Aiguader, 88, 08003, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 08036, Madrid, Spain.; Universitat Pompeu Fabra (UPF), Barcelona, Spain.; Hospital del Mar Medical Research Institute (IMIM), 08003, Barcelona, Spain.
Castaño-Vinyals G; Barcelona Institute for Global Health (ISGlobal), Doctor Aiguader, 88, 08003, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 08036, Madrid, Spain.; Universitat Pompeu Fabra (UPF), Barcelona, Spain.; Hospital del Mar Medical Research Institute (IMIM), 08003, Barcelona, Spain.
Rubio R; Barcelona Institute for Global Health (ISGlobal), Doctor Aiguader, 88, 08003, Barcelona, Spain.
Vidal M; Barcelona Institute for Global Health (ISGlobal), Doctor Aiguader, 88, 08003, Barcelona, Spain.
Jiménez A; Barcelona Institute for Global Health (ISGlobal), Doctor Aiguader, 88, 08003, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 08036, Madrid, Spain.
Prados E; Barcelona Institute for Global Health (ISGlobal), Doctor Aiguader, 88, 08003, Barcelona, Spain.
Carreras A; Genomes for Life-GCAT lab. Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain.
Cortés B; Genomes for Life-GCAT lab. Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain.
Blay N; Genomes for Life-GCAT lab. Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain.
Bañuls M; Barcelona Institute for Global Health (ISGlobal), Doctor Aiguader, 88, 08003, Barcelona, Spain.
Pleguezuelos V; Banc de Sang i Teixits (BST), Barcelona, Spain.
Melero NR; Centre for Genomic Regulation (CRG), Barcelona, Spain.
Serra P; Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Barcelona, Spain.
Parras D; Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Barcelona, Spain.
Izquierdo L; Barcelona Institute for Global Health (ISGlobal), Doctor Aiguader, 88, 08003, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Barcelona, Spain.
Santamaría P; Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Barcelona, Spain.; Department of Microbiology, Immunology and Infectious Diseases, Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Carolis C; Centre for Genomic Regulation (CRG), Barcelona, Spain.
Papantoniou K; Department of Epidemiology, Center for Public Health, Medical University of Vienna, Vienna, Austria.
Goldberg X; Barcelona Institute for Global Health (ISGlobal), Doctor Aiguader, 88, 08003, Barcelona, Spain.
Aguilar R; Barcelona Institute for Global Health (ISGlobal), Doctor Aiguader, 88, 08003, Barcelona, Spain.
Garcia-Aymerich J; Barcelona Institute for Global Health (ISGlobal), Doctor Aiguader, 88, 08003, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 08036, Madrid, Spain.; Universitat Pompeu Fabra (UPF), Barcelona, Spain.; Hospital del Mar Medical Research Institute (IMIM), 08003, Barcelona, Spain.
de Cid R; Genomes for Life-GCAT lab. Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain.
Kogevinas M; Barcelona Institute for Global Health (ISGlobal), Doctor Aiguader, 88, 08003, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 08036, Madrid, Spain.; Universitat Pompeu Fabra (UPF), Barcelona, Spain.; Hospital del Mar Medical Research Institute (IMIM), 08003, Barcelona, Spain.
Dobaño C; Barcelona Institute for Global Health (ISGlobal), Doctor Aiguader, 88, 08003, Barcelona, Spain. .; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Barcelona, Spain. .; Barcelona Institute for Global Health (ISGlobal), Carrer Rosello 132, 08036, Barcelona, Spain. .
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2022 Sep 16; Vol. 20 (1), pp. 347. Date of Electronic Publication: 2022 Sep 16.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/prevention & control
Viral Vaccines*/pharmacology
Antibody Formation ; COVID-19 Testing ; COVID-19 Vaccines ; Cohort Studies ; Humans ; Immunoglobulin A ; Immunoglobulin G ; Immunoglobulin M ; Middle Aged ; Nucleoproteins ; SARS-CoV-2 ; Spain/epidemiology ; Vaccination
Czasopismo naukowe
Tytuł:
Cerebral Venous Sinus Thrombosis Following COVID-19 and Otogenic Infection: A Diagnostic and Therapeutic Dilemma Followed by mRNA COVID-19 Vaccination.
Autorzy:
Cline L; Department of Pharmacy and Internal Medicine, Kaiser Permanente, Temple Hills, MD, USA.
Nguyen HT; Department of Internal Medicine, Kaiser Permanente, Temple Hills, MD, USA.
Olenik A; Department of Pharmacy and Internal Medicine, Kaiser Permanente, Temple Hills, MD, USA.
Pokaż więcej
Źródło:
The Permanente journal [Perm J] 2022 Sep 14; Vol. 26 (3), pp. 128-134. Date of Electronic Publication: 2022 Jul 20.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
COVID-19*
COVID-19 Vaccines*/adverse effects
Sinus Thrombosis, Intracranial*/diagnosis
Sinus Thrombosis, Intracranial*/drug therapy
Sinus Thrombosis, Intracranial*/etiology
Aged ; Anti-Bacterial Agents/therapeutic use ; Anticoagulants/therapeutic use ; COVID-19 Testing ; Female ; Humans ; RNA, Messenger ; Vaccination/adverse effects
Czasopismo naukowe
Tytuł:
Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July-November 2021.
Autorzy:
Starrfelt J; Department of Infection Control and Preparedness, Norwegian Institute of Public Health, Postboks 222 Skøyen, 0213, Oslo, Norway. .
Danielsen AS; Department of Infection Control and Preparedness, Norwegian Institute of Public Health, Postboks 222 Skøyen, 0213, Oslo, Norway.; Department of Microbiology, Oslo University Hospital, Oslo, Norway.
Buanes EA; Norwegian Intensive Care and Pandemic Registry (NIPaR), Helse Bergen Health Trust, Bergen, Norway.; Department of Anaesthesiology and Intensive Care Haukeland University Hospital, Bergen, Norway.
Juvet LK; Department of Infection Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway.
Lyngstad TM; Department of Infection Control and Preparedness, Norwegian Institute of Public Health, Postboks 222 Skøyen, 0213, Oslo, Norway.
Rø GØI; Department of Development and Analytics, Norwegian Institute of Public Health, Oslo, Norway.
Veneti L; Department of Infection Control and Preparedness, Norwegian Institute of Public Health, Postboks 222 Skøyen, 0213, Oslo, Norway.
Watle SV; Department of Infection Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway.
Meijerink H; Department of Infection Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway.
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2022 Sep 02; Vol. 20 (1), pp. 278. Date of Electronic Publication: 2022 Sep 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
Influenza Vaccines*
Influenza, Human*/prevention & control
Adult ; BNT162 Vaccine ; COVID-19 Vaccines ; ChAdOx1 nCoV-19 ; Cohort Studies ; Hospitalization ; Humans ; Norway/epidemiology ; SARS-CoV-2 ; Vaccine Efficacy
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł:
COVID-19 vaccination status and testing rates in Finland-A potential cause for bias in observational vaccine effectiveness analysis.
Autorzy:
Kuitunen I; Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.; Mikkeli Central Hospital, Mikkeli, Finland.
Uimonen M; Central Finland Hospital Nova, Jyväskylä, Finland.
Seppälä SJ; Mikkeli Central Hospital, Mikkeli, Finland.
Ponkilainen VT; Central Finland Hospital Nova, Jyväskylä, Finland.
Pokaż więcej
Źródło:
Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2022 Sep; Vol. 16 (5), pp. 842-845. Date of Electronic Publication: 2022 Apr 27.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
COVID-19 Vaccines*
COVID-19 Testing ; Finland/epidemiology ; Humans ; Observational Studies as Topic ; Vaccination ; Vaccine Efficacy
Czasopismo naukowe
Tytuł:
[Effectiveness of BNT162b2 vaccine to preventing COVID-19 in healthcare personnel].
Autorzy:
Chico-Sánchez P; Unidad de Epidemiología, Servicio de Medicina Preventiva, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, España.
Gras-Valentí P; Unidad de Epidemiología, Servicio de Medicina Preventiva, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, España.
Algado-Sellés N; Unidad de Epidemiología, Servicio de Medicina Preventiva, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, España.
Merino-Lucas E; Unidad de Enfermedades Infecciosas, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, España.
Rodríguez-Díaz JC; Servicio de Microbiología, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, España.
Ronda-Pérez E; Grupo de Investigación en Salud Pública, Universidad de Alicante, Alicante, España; CIBER de Epidemiología y Salud Pública (CIBERESP), España.
Sánchez-Payá J; Unidad de Epidemiología, Servicio de Medicina Preventiva, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, España. Electronic address: sanchez_.
Pokaż więcej
Transliterated Title:
Efectividad de la vacuna BNT162b2 para prevenir la COVID-19 en personal sanitario.
Corporate Authors:
Grupo COVID-19 de Medicina Preventiva
Źródło:
Gaceta sanitaria [Gac Sanit] 2022 Sep-Oct; Vol. 36 (5), pp. 484-487. Date of Electronic Publication: 2021 Nov 26.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
Influenza Vaccines*
BNT162 Vaccine ; COVID-19 Vaccines ; Delivery of Health Care ; Health Personnel ; Humans ; SARS-CoV-2
Czasopismo naukowe
Tytuł:
The risk of contracting SARS-CoV-2 or developing COVID-19 for people with cancer: A systematic review of the early evidence.
Autorzy:
Carle C; The Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Australia.
Hughes S; The Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Australia.
Freeman V; The Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Australia.
Campbell D; The Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Australia.
Egger S; The Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Australia.
Caruana M; The Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Australia.
Hui H; The Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Australia.
Yap S; The Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Australia.
Deandrea S; Directorate General for Health, Lombardy Region, Milano, Italy; Environmental Health Unit, Agency for Health Protection, Pavia, Italy.
Onyeka TC; Department of Anaesthesia/Pain & Palliative Care Unit, Multidisciplinary Oncology Centre, College of Medicine, University of Nigeria, Nigeria.
IJzerman MJ; University of Melbourne, Centre for Cancer Research and Centre for Health Policy, Australia; Department of Cancer Research, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.
Ginsburg O; Perlmutter Cancer Center and the Department of Population Health, NYU Grossman School of Medicine, New York, United States.
Bray F; Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France.
Sullivan R; King's Institute of Cancer Policy, King's College, London, United Kingdom.
Aggarwal A; King's Institute of Cancer Policy, King's College, London, United Kingdom; Department of Oncology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Peacock SJ; Canadian Centre for Applied Research in Cancer Control (ARCC), Canada; Cancer Control Research, BC Cancer, Canada; Faculty of Health Sciences, Simon Fraser University, Canada.
Chan KKW; Canadian Centre for Applied Research in Cancer Control (ARCC), Canada; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Canada.
Hanna TP; Division of Cancer Care and Epidemiology, Cancer Research Institute at Queen's University, Kingston, ON, Canada; Department of Oncology and Department of Public Health Sciences, Queen's University, Kingston, ON, Canada.
Soerjomataram I; Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France.
O'Connell DL; The Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Australia.
Canfell K; The Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Australia. Electronic address: .
Steinberg J; The Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Australia. Electronic address: .
Pokaż więcej
Źródło:
Journal of cancer policy [J Cancer Policy] 2022 Sep; Vol. 33, pp. 100338. Date of Electronic Publication: 2022 Jun 06.
Typ publikacji:
Journal Article; Review; Systematic Review; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*/epidemiology
Neoplasms*/epidemiology
COVID-19 Testing ; COVID-19 Vaccines ; Humans ; SARS-CoV-2
Czasopismo naukowe
Tytuł:
Predictors of poor serologic response to COVID-19 vaccine in patients with cancer: a systematic review and meta-analysis.
Autorzy:
Yang W; Department of Physiology, West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, Sichuan 610041, People's Republic of China.
Zhang D; Equipment and Material Department, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, People's Republic of China.
Li Z; Department of Forensic Pathology, West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, Sichuan 610041, People's Republic of China.
Zhang K; Department of Forensic Pathology, West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, Sichuan 610041, People's Republic of China. Electronic address: .
Pokaż więcej
Źródło:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Sep; Vol. 172, pp. 41-50. Date of Electronic Publication: 2022 Jun 02.
Typ publikacji:
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:
COVID-19*/prevention & control
Neoplasms*/therapy
COVID-19 Testing ; COVID-19 Vaccines ; Humans ; Male ; Seroconversion ; Vaccination
Czasopismo naukowe
Tytuł:
A Systematic Review and Meta-Analysis of Serologic Response following Coronavirus Disease 2019 (COVID-19) Vaccination in Solid Organ Transplant Recipients.
Autorzy:
Sakuraba A; Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, The University of Chicago Medicine, 5841 S. Maryland Ave. MC 4076, Chicago, IL 60637, USA.
Luna A; Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, The University of Chicago Medicine, 5841 S. Maryland Ave. MC 4076, Chicago, IL 60637, USA.
Micic D; Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, The University of Chicago Medicine, 5841 S. Maryland Ave. MC 4076, Chicago, IL 60637, USA.
Pokaż więcej
Źródło:
Viruses [Viruses] 2022 Aug 19; Vol. 14 (8). Date of Electronic Publication: 2022 Aug 19.
Typ publikacji:
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:
COVID-19*/prevention & control
COVID-19 Vaccines*/adverse effects
Organ Transplantation*/adverse effects
Vaccines*
Antibodies, Viral ; BNT162 Vaccine ; COVID-19 Testing ; Humans ; Vaccination/methods ; Vaccines, Synthetic ; mRNA Vaccines
Czasopismo naukowe
Tytuł:
Can we get out of the COVID pandemic without adequate vaccination coverage in the pediatric population?
Autorzy:
Esposito S; Department of Medicine and Surgery, Pediatric Clinic, University of Parma, Via Gramsci 14, 43126, Parma, Italy. .
Giordano R; Department of Public Health, AUSL Parma, Parma, Italy.
Paini G; Department of Public Health, AUSL Parma, Parma, Italy.
Puntoni M; Research and Innovation Unit, University Hospital of Parma, Parma, Italy.
Principi N; Università degli Studi di Milano, Milan, Italy.
Caminiti C; Research and Innovation Unit, University Hospital of Parma, Parma, Italy.
Pokaż więcej
Źródło:
Italian journal of pediatrics [Ital J Pediatr] 2022 Aug 19; Vol. 48 (1), pp. 150. Date of Electronic Publication: 2022 Aug 19.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
Pandemics*/prevention & control
Adolescent ; Adult ; Aged ; COVID-19 Vaccines ; Child ; Child, Preschool ; Humans ; Infant ; SARS-CoV-2 ; Vaccination ; Vaccination Coverage
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł:
Longitudinal change in SARS-CoV-2 seroprevalence in 3-to 16-year-old children: The Augsburg Plus study.
Autorzy:
Leone V; Chair of Epidemiology, University of Augsburg, University Hospital Augsburg, Augsburg, Germany.
Meisinger C; Chair of Epidemiology, University of Augsburg, University Hospital Augsburg, Augsburg, Germany.
Temizel S; Department of Hygiene and Environmental Medicine, University Hospital Augsburg, Augsburg, Germany.
Kling E; Institute of Laboratory Medicine and Microbiology University Hospital Augsburg, Augsburg, Germany.
Gerstlauer M; Paediatric and Adolescent Medicine University Hospital Augsburg, Augsburg, Germany.
Frühwald MC; Paediatric and Adolescent Medicine University Hospital Augsburg, Augsburg, Germany.
Burkhardt K; Institute of Laboratory Medicine and Microbiology University Hospital Augsburg, Augsburg, Germany.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Aug 11; Vol. 17 (8), pp. e0272874. Date of Electronic Publication: 2022 Aug 11 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*/diagnosis
COVID-19*/epidemiology
SARS-CoV-2*
Adolescent ; Antibodies, Viral ; COVID-19 Testing ; COVID-19 Vaccines ; Child ; Child, Preschool ; Clinical Laboratory Techniques ; Humans ; Immunoglobulin G ; Seroepidemiologic Studies ; Spike Glycoprotein, Coronavirus
Czasopismo naukowe
Tytuł:
Adherence to Covid-19 mitigation measures and its associated factors among health care workers at referral hospitals in Amhara regional state of Ethiopia.
Autorzy:
Aemro A; Department of Medical Nursing, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Fentie B; Department Pediatrics and Child Health Nursing, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Wassie M; Department of Medical Nursing, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Aug 05; Vol. 17 (8), pp. e0272570. Date of Electronic Publication: 2022 Aug 05 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
COVID-19 Testing ; COVID-19 Vaccines ; Cross-Sectional Studies ; Ethiopia/epidemiology ; Health Personnel ; Hospitals ; Humans ; Referral and Consultation
Czasopismo naukowe
Tytuł:
COVID-19 vaccine uptake among physicians during the second wave of COVID-19 pandemic: Attitude, intentions, and determinants: A cross-sectional study.
Autorzy:
Amer SA; Department of Public Health and Community Medicine, Faculty of Medicine Zagazig University, Zagazig, Egypt.; Member of the Royal College of General Practitioners, London, United Kingdom.; Mental Health in Primary Care, Nova University, Lisbona, Portugal.
Shah J; New York State Department of Health, New York, NY, United States.
Abd-Ellatif EE; Department of Public Health and Community Medicine, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
El Maghawry HA; Department of Public Health and Community Medicine, Faculty of Medicine Zagazig University, Zagazig, Egypt.
Pokaż więcej
Źródło:
Frontiers in public health [Front Public Health] 2022 Aug 03; Vol. 10, pp. 823217. Date of Electronic Publication: 2022 Aug 03 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
Physicians*
COVID-19 Vaccines ; Cross-Sectional Studies ; Female ; Health Knowledge, Attitudes, Practice ; Humans ; Intention ; Male ; Pandemics
Czasopismo naukowe
Tytuł:
Uncovering SARS-COV-2 vaccine uptake and COVID-19 impacts among First Nations, Inuit and Métis Peoples living in Toronto and London, Ontario.
Autorzy:
Smylie J; Well Living House (Smylie, McConkey, Brar), St. Michael's Hospital; Dalla Lana School of Public Health (Smylie, McConkey, Rachlis, Avery), University of Toronto; ICES (Smylie, Rachlis, Mecredy); Princess Margaret Cancer Centre (Avery), University Health Network; Seventh Generations Midwives Toronto (Bourgeois); Call Auntie Clinic (Bourgeois); School of Kinesiology and Health Science (Rotondi), York University, Toronto, Ont.; Southwest Ontario Aboriginal Health Access Centre (Dokis, Vandevenne), London, Ont. .
McConkey S; Well Living House (Smylie, McConkey, Brar), St. Michael's Hospital; Dalla Lana School of Public Health (Smylie, McConkey, Rachlis, Avery), University of Toronto; ICES (Smylie, Rachlis, Mecredy); Princess Margaret Cancer Centre (Avery), University Health Network; Seventh Generations Midwives Toronto (Bourgeois); Call Auntie Clinic (Bourgeois); School of Kinesiology and Health Science (Rotondi), York University, Toronto, Ont.; Southwest Ontario Aboriginal Health Access Centre (Dokis, Vandevenne), London, Ont.
Rachlis B; Well Living House (Smylie, McConkey, Brar), St. Michael's Hospital; Dalla Lana School of Public Health (Smylie, McConkey, Rachlis, Avery), University of Toronto; ICES (Smylie, Rachlis, Mecredy); Princess Margaret Cancer Centre (Avery), University Health Network; Seventh Generations Midwives Toronto (Bourgeois); Call Auntie Clinic (Bourgeois); School of Kinesiology and Health Science (Rotondi), York University, Toronto, Ont.; Southwest Ontario Aboriginal Health Access Centre (Dokis, Vandevenne), London, Ont.
Avery L; Well Living House (Smylie, McConkey, Brar), St. Michael's Hospital; Dalla Lana School of Public Health (Smylie, McConkey, Rachlis, Avery), University of Toronto; ICES (Smylie, Rachlis, Mecredy); Princess Margaret Cancer Centre (Avery), University Health Network; Seventh Generations Midwives Toronto (Bourgeois); Call Auntie Clinic (Bourgeois); School of Kinesiology and Health Science (Rotondi), York University, Toronto, Ont.; Southwest Ontario Aboriginal Health Access Centre (Dokis, Vandevenne), London, Ont.
Mecredy G; Well Living House (Smylie, McConkey, Brar), St. Michael's Hospital; Dalla Lana School of Public Health (Smylie, McConkey, Rachlis, Avery), University of Toronto; ICES (Smylie, Rachlis, Mecredy); Princess Margaret Cancer Centre (Avery), University Health Network; Seventh Generations Midwives Toronto (Bourgeois); Call Auntie Clinic (Bourgeois); School of Kinesiology and Health Science (Rotondi), York University, Toronto, Ont.; Southwest Ontario Aboriginal Health Access Centre (Dokis, Vandevenne), London, Ont.
Brar R; Well Living House (Smylie, McConkey, Brar), St. Michael's Hospital; Dalla Lana School of Public Health (Smylie, McConkey, Rachlis, Avery), University of Toronto; ICES (Smylie, Rachlis, Mecredy); Princess Margaret Cancer Centre (Avery), University Health Network; Seventh Generations Midwives Toronto (Bourgeois); Call Auntie Clinic (Bourgeois); School of Kinesiology and Health Science (Rotondi), York University, Toronto, Ont.; Southwest Ontario Aboriginal Health Access Centre (Dokis, Vandevenne), London, Ont.
Bourgeois C; Well Living House (Smylie, McConkey, Brar), St. Michael's Hospital; Dalla Lana School of Public Health (Smylie, McConkey, Rachlis, Avery), University of Toronto; ICES (Smylie, Rachlis, Mecredy); Princess Margaret Cancer Centre (Avery), University Health Network; Seventh Generations Midwives Toronto (Bourgeois); Call Auntie Clinic (Bourgeois); School of Kinesiology and Health Science (Rotondi), York University, Toronto, Ont.; Southwest Ontario Aboriginal Health Access Centre (Dokis, Vandevenne), London, Ont.
Dokis B; Well Living House (Smylie, McConkey, Brar), St. Michael's Hospital; Dalla Lana School of Public Health (Smylie, McConkey, Rachlis, Avery), University of Toronto; ICES (Smylie, Rachlis, Mecredy); Princess Margaret Cancer Centre (Avery), University Health Network; Seventh Generations Midwives Toronto (Bourgeois); Call Auntie Clinic (Bourgeois); School of Kinesiology and Health Science (Rotondi), York University, Toronto, Ont.; Southwest Ontario Aboriginal Health Access Centre (Dokis, Vandevenne), London, Ont.
Vandevenne S; Well Living House (Smylie, McConkey, Brar), St. Michael's Hospital; Dalla Lana School of Public Health (Smylie, McConkey, Rachlis, Avery), University of Toronto; ICES (Smylie, Rachlis, Mecredy); Princess Margaret Cancer Centre (Avery), University Health Network; Seventh Generations Midwives Toronto (Bourgeois); Call Auntie Clinic (Bourgeois); School of Kinesiology and Health Science (Rotondi), York University, Toronto, Ont.; Southwest Ontario Aboriginal Health Access Centre (Dokis, Vandevenne), London, Ont.
Rotondi MA; Well Living House (Smylie, McConkey, Brar), St. Michael's Hospital; Dalla Lana School of Public Health (Smylie, McConkey, Rachlis, Avery), University of Toronto; ICES (Smylie, Rachlis, Mecredy); Princess Margaret Cancer Centre (Avery), University Health Network; Seventh Generations Midwives Toronto (Bourgeois); Call Auntie Clinic (Bourgeois); School of Kinesiology and Health Science (Rotondi), York University, Toronto, Ont.; Southwest Ontario Aboriginal Health Access Centre (Dokis, Vandevenne), London, Ont.
Pokaż więcej
Źródło:
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne [CMAJ] 2022 Aug 02; Vol. 194 (29), pp. E1018-E1026.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
Indians, North American*
Adult ; COVID-19 Testing ; COVID-19 Vaccines ; Canada/epidemiology ; Humans ; Inuits ; London/epidemiology ; Ontario/epidemiology ; SARS-CoV-2
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz